ACS: Many Cancer Patients Face Lasting Financial Difficulties
By Elana Gotkine HealthDay Reporter
MONDAY, Oct. 28, 2024 -- Many patients with cancer diagnoses experience lasting financial difficulties, according to two studies presented at the annual meeting of the American College of Surgeons, held from Oct. 19 to 22 in San Francisco.
Jorge L. Gomez-Mayorga, M.D., from Beth Deaconess Medical Center in Boston, and colleagues conducted a difference-in-differences analysis comparing 99,175 individuals with cancer and 188,875 controls to examine financial outcomes after a cancer diagnosis. The researchers found that patients with cancer experienced increases in total collections, medical collections, and bankruptcy rates compared with controls, as well as decreases in credit scores. A decline in credit score was seen for survivors of bladder, liver, ovarian, colorectal, and lung cancers, which persisted for years after diagnosis, compared with a gradual increase in credit score seen in the control population.
Anastasia Bogdanovski, M.D., from Beth Deaconess Medical Center in Boston, and colleagues examined factors associated with financial toxicity in colorectal cancer patients in Massachusetts. The outcome credit score was assessed over time. Data were included for 7,227 colorectal cancer patients with median financial follow-up of 5.3 years. The researchers found that the mean credit score was 716 points, with significant variation seen in points: −11 for younger than 62 years; −78 and −62 for Black and Hispanic race, respectively; −28 for unmarried; −14 for Area Deprivation Index below median; −5 for nonhomeowner; −18 for income below median of $52,000; and −10 and −7 for distant or regional disease, respectively. Notable disparities were observed among cancer and treatment types.
"Further research is needed, but I think financial security should be a priority in cancer care," coauthor from both studies Benjamin C. James, M.D., also from Beth Israel Deaconess Medical Center, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Medical Debt in Collections Persists After Cancer Diagnosis
TUESDAY, Sept. 2, 2025 -- Modest amounts of medical debt in collections persist for years after cancer diagnosis, according to a study published online Aug. 28 in JAMA...
Cancer Survivors More Likely to Take Rx for Mental Health Conditions
THURSDAY, Aug. 28, 2025 -- U.S. cancer survivors are significantly more likely to take medications for depression and anxiety compared with noncancer survivors, according to a...
GLP-1 Receptor Agonist Use Linked to Reduced Overall Risk for Cancer in Adults With Obesity
TUESDAY, Aug. 26, 2025 -- For adults with obesity, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced overall risk for cancer, including lower...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.